L van Eijndhoven

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A clinical phase II trial with the RIVM hexavalent OMV vaccine containing six different PorAs was carried out in toddlers (2-3 years) and schoolchildren (7-8 years) in The Netherlands. Children were(More)
  • 1